Abingdon HealthABDXF +8.93%49 Market Cap is $37.28 Mil as of Jun. 25, 2026. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.21 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 219 Medical Diagnostics & Research companies, Abingdon Health ranks worse than 57.53% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Abingdon Health's share price for the quarter that ended in Dec. 2025 was $0.07. Abingdon Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 251.08 Mil. Therefore, Abingdon Health's market cap for the quarter that ended in Dec. 2025 was $17.58 Mil.
Abingdon Health's quarterly market cap
stayed the same
from Dec. 2024 ($13.55 Mil) to Jun. 2025 ($13.55 Mil) but then
increased
from Jun. 2025 ($13.55 Mil) to Dec. 2025 ($17.58 Mil).
Abingdon Health's annual market cap
increased
from Jun. 2023 ($8.52 Mil) to Jun. 2024 ($8.87 Mil) and
increased
from Jun. 2024 ($8.87 Mil) to Jun. 2025 ($13.55 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Abingdon Health's Enterprise Value for Today is $37.09 Mil.
Abingdon Health (OTCPK:ABDXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Abingdon Health Market Cap Related Terms
Abingdon Health Market Cap Historical Data
* Premium members only.
The historical data trend for Abingdon Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Abingdon Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abingdon Health Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Abingdon Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Abingdon Health's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abingdon Health (ABDXF) has a Market Cap of $37.28 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Abingdon Health and its competitors. According to the industry distribution chart, Abingdon Health ranks #126 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 57.5%.
Is Abingdon Health's Market Cap too high?
Abingdon Health's current Market Cap is $37.28 Mil. The Medical Diagnostics & Research industry median Market Cap is 56.68. Abingdon Health's value of $37.28 Mil is 34.2% below this industry median. Based on the distribution chart, Abingdon Health ranks #126 out of 219 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Abingdon Health ranks #126 out of 219 companies for Market Cap. This places Abingdon Health in the lower half of its industry. The industry median Market Cap is 56.68. Abingdon Health's value of $37.28 Mil is 34.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 56.68, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abingdon Health's current Market Cap of $37.28 Mil is 34.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Abingdon Health and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 56.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abingdon Health's current Market Cap is $37.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.21, compared to a current price of $0.15 — trading 27.4% below its estimated fair value. The current Market Cap is $37.28 Mil and 34.2% below the Medical Diagnostics & Research industry median of 56.68. Abingdon Health's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Market Cap is $37.28 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abingdon Health (ABDXF) Overvalued in 2026?
Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued.
The current stock price of $0.15 is trading 27.4% below its estimated GF Value™ of $0.21.
GuruFocus considers Abingdon Health to be Modestly Undervalued.
Key valuation signals for ABDXF:
Market Cap: $37.28 Mil
GF Value™: $0.21 vs. price of $0.15 (27.4% below fair value)
Industry Position: 34.2% below the Medical Diagnostics & Research median (#126 of 219)
No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score
Get the complete analysis for ABDXF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABDXF has been successfully added to your 
